
AstraZeneca’s Next AI Test Is Spotting Early Signs of Drug Harm
Tremont AI’s research collaboration with AstraZeneca will develop and evaluate foundation models for preclinical toxicologic pathology, where rare tissue changes can be difficult to distinguish from normal variation.






















